Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
BMC Infect Dis ; 16(1): 553, 2016 Oct 10.
Article in English | MEDLINE | ID: mdl-27724919

ABSTRACT

BACKGROUND: The best surgical modality for treating chronic periprosthetic hip infections remains controversial, with a lack of randomised controlled studies. The aim of this systematic review is to compare the infection recurrence rate after a single-stage versus a two-stage exchange arthroplasty, and the rate of cemented versus cementless single-stage exchange arthroplasty for chronic periprosthetic hip infections. METHODS: We searched for eligible studies published up to December 2015. Full text or abstract in English were reviewed. We included studies reporting the infection recurrence rate as the outcome of interest following single- or two-stage exchange arthroplasty, or both, with a minimum follow-up of 12 months. Two reviewers independently abstracted data and appraised quality assessment. RESULTS: After study selection, 90 observational studies were included. The majority of studies were focused on a two-stage hip exchange arthroplasty (65 %), 18 % on a single-stage exchange, and only a 17 % were comparative studies. There was no statistically significant difference between a single-stage versus a two-stage exchange in terms of recurrence of infection in controlled studies (pooled odds ratio of 1.37 [95 % CI = 0.68-2.74, I2 = 45.5 %]). Similarly, the recurrence infection rate in cementless versus cemented single-stage hip exchanges failed to demonstrate a significant difference, due to the substantial heterogeneity among the studies. CONCLUSION: Despite the methodological limitations and the heterogeneity between single cohorts studies, if we considered only the available controlled studies no superiority was demonstrated between a single- and two-stage exchange at a minimum of 12 months follow-up. The overalapping of confidence intervals related to single-stage cementless and cemented hip exchanges, showed no superiority of either technique.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Bone Cements , Hip Prosthesis/adverse effects , Prosthesis-Related Infections/surgery , Arthroplasty, Replacement, Hip/instrumentation , Chronic Disease , Humans , Recurrence , Treatment Outcome
2.
BMC Musculoskelet Disord ; 17: 52, 2016 Feb 01.
Article in English | MEDLINE | ID: mdl-26832360

ABSTRACT

BACKGROUND: The best surgical modality for treating chronic periprosthetic shoulder infections has not been established, with a lack of randomised comparative studies. This systematic review compares the infection eradication rate and functional outcomes after single- or two-stage shoulder exchange arthroplasty, to permanent spacer implant or resection arthroplasty. METHODS: Full-text papers and those with an abstract in English published from January 2000 to June 2014, identified through international databases, such as EMBASE and PubMed, were reviewed. Those reporting the success rate of infection eradication after a single-stage exchange, two-stage exchange, resection arthroplasty or permanent spacer implant, with a minimum follow-up of 6 months and sample size of 5 patients were included. RESULTS: Eight original articles reporting the results after resection arthroplasty (n = 83), 6 on single-stage exchange (n = 75), 13 on two-stage exchange (n = 142) and 8 papers on permanent spacer (n = 68) were included. The average infection eradication rate was 86.7 % at a mean follow-up of 39.8 months (SD 20.8) after resection arthroplasty, 94.7 % at 46.8 months (SD 17.6) after a single-stage exchange, 90.8 % at 37.9 months (SD 12.8) after two-stage exchange, and 95.6 % at 31.0 months (SD 9.8) following a permanent spacer implant. The difference was not statistically significant (p = 0.650). Regarding functional outcome, patients treated with single-stage exchange had statistically significant better postoperative Constant scores (mean 51, SD 13) than patients undergoing a two-stage exchange (mean 44, SD 9), resection arthroplasty (mean 32, SD 7) or a permanent spacer implant (mean 31, SD 9) (p = 0.029). However, when considering studies comparing pre- and post-operative Constant scores, the difference was not statistically significant. CONCLUSION: This systematic review failed to demonstrate a clear difference in infection eradication and functional improvement between all four treatment modalities for established periprosthetic shoulder infection. The relatively low number of patients and the methodological limitations of the studies available point out the need for well designed multi-center trials to further assess the best treatment option of peri-prosthetic shoulder infection.


Subject(s)
Arthroplasty, Replacement/adverse effects , Arthroplasty, Replacement/instrumentation , Device Removal , Joint Prosthesis/adverse effects , Prosthesis-Related Infections/surgery , Shoulder Joint/surgery , Biomechanical Phenomena , Device Removal/adverse effects , Humans , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/microbiology , Prosthesis-Related Infections/physiopathology , Recovery of Function , Reoperation , Risk Factors , Shoulder Joint/microbiology , Shoulder Joint/physiopathology , Treatment Outcome
3.
Minerva Ginecol ; 45(9): 449-52, 1993 Sep.
Article in Italian | MEDLINE | ID: mdl-8255508

ABSTRACT

Induction of labour using extra-amniotic intrauterine estrogens. Personal experience. The study was carried out in a series of 20 primagravidae in whom it was necessary to induce labour. The method used entailed the introduction, via an extra-amniotic transcervical route, of approximately 16 mg of estrogen paste. There is a full discussion of the technical details and results obtained which appear to be encouraging for the routine use of this method.


Subject(s)
Estradiol Congeners/administration & dosage , Labor, Induced/methods , Amnion , Female , Humans , Ointments , Parity , Pregnancy , Pregnancy Outcome , Uterus
SELECTION OF CITATIONS
SEARCH DETAIL
...